Cigna to Preauthorize Genetic Tests

Cigna is implementing a new program that requires genetic counseling and pre-authorization for certain genetic tests. Starting on September 16, Cigna will require patients to undergo genetic counseling before it will approve genetic tests for breast cancer, colon cancer, and long QT syndrome (a rare heart condition). This is an important development and clinical laboratory executives can expect to see other health insurers take similar steps. Cigna wants to control costs and improve the appropriateness of ordering expensive genetic tests. It will start with tests for these conditions and may require counseling for other types of genetic tests if this program is successful. Industry observers expect other health insurers will follow Cigna’s example and also require genetic counseling for a compelling reason: all insurers recognize that more than 50% of all genetic tests may be ordered inappropriately, experts say.